Physician Perspectives on the Food and Drug Administration’s Decision to Grant Accelerated Approval to Aducanumab for Alzheimer’s Disease

Program On Regulation, Therapeutics, And Law (PORTAL)
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital • Harvard Medical School
41 Avenue Louis Pasteur, Suite 0B17, Boston, MA 02115